formoterol fumarate inhalation solution

DRUG2 trials

Sponsors

Dey, Joincare Pharmaceutical Group Industry Co., Ltd

Conditions

COPDCOPD (Chronic Obstructive Pulmonary Disease)Chronic Obstructive Pulmonary Disease

Phase 2

Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD

CompletedNCT07450482

Joincare Pharmaceutical Group Industry Co., LtdCOPD, COPD (Chronic Obstructive Pulmonary Disease)

Start: 2025-07-22End: 2025-09-25Updated: 2026-03-04

Phase 3

Study in Subjects Greater Than 40 Years of Age With COPD

CompletedNCT00507234

DeyChronic Obstructive Pulmonary Disease

Start: 2007-03-31End: 2008-04-30Updated: 2010-11-11

Related Papers

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

2009-06-0124 citations